Osteopathic Manual Treatment for Hemiplegic Shoulder Pain and Upper Extremity Function in Stroke Patients

Sponsor
University of Wisconsin, Madison (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06098508
Collaborator
(none)
10
1
2
6
1.7

Study Details

Study Description

Brief Summary

This study assesses the feasibility and safety of performing osteopathic manual treatment (OMT) for hemiplegic shoulder pain in stroke patients. This study's participants will be adults with a first-time stroke diagnosis and shoulder pain on the same side affected by stroke. Eligible participants will be placed on study for approximately 6 weeks and given either OMT or a sham treatment each week.

Condition or Disease Intervention/Treatment Phase
  • Other: Osteopathic Manual Treatment
  • Other: Sham Treatment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Other members of the study team, such as those who recruit, screen, and coordinate research visits, will be masked. Additionally, the occupational therapist who performs baseline pain ratings and arm function assessments will also be masked.
Primary Purpose:
Treatment
Official Title:
The Effects of Osteopathic Manual Treatment on Hemiplegic Shoulder Pain and Upper Extremity Function in Stroke Patients: A Pilot Study
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Osteopathic Manual Treatment

Other: Osteopathic Manual Treatment
This study will be using osteopathic manual therapy as the primary intervention. Osteopathic manual therapy (OMT) is a hands-on treatment that is performed by a specially trained physician known as a Doctor of Osteopathic Medicine (DO). This treatment can be used to diagnose and treat somatic dysfunctions, which are palpable areas of tightness, misalignment, and/or restricted motion within the musculoskeletal system and its related vascular and neural structures. A combination of myofascial release, strain/counterstain, soft tissue, balanced ligamentous release, facilitated positional release and muscle energy techniques will be used for the OMT treatment.

Sham Comparator: Sham Treatment Arm

Other: Sham Treatment
The sham treatment will include a hands-on evaluation typically used to diagnose somatic dysfunctions, but no treatment will be performed. The sham treatment will assess the upper extremities/scapulae, ribs, cervical spine, thoracic spine, thoracic inlet, and occipital-atlantal regions.

Outcome Measures

Primary Outcome Measures

  1. Feasibility Assessment [From enrollment to the end of treatment at 6 weeks]

    The study team will assess feasibility by tracking participant recruitment, randomization, and retention. The ability to carry out the intervention protocol to completion in these participants will be assessed. Feasibility will be confirmed if 10 patients are randomized and at least 80% complete the study within the planned 1-year timeline.

Secondary Outcome Measures

  1. Safety Assessment [From enrollment to the end of treatment at 6 weeks]

    The study team will also assess the safety of performing osteopathic manual therapy in stroke patients with hemiplegic shoulder pain. Any reported adverse events (AE) and severe adverse events (SAE) will be tracked and monitored.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients must be at least 18 years or older to participate in the study

  • Presence of shoulder pain on the side of the body affected by stroke

  • Patients must have a diagnosis of a first-time stroke within the past year

  • Stroke type must be right middle cerebral artery, brainstem, or subcortical ischemic stroke

Exclusion Criteria:
  • Presence of an active systemic or localized infection requiring antibiotic therapy

  • Presence of fracture in the area being treated

  • Presence of open wound in the area being treated

  • Presence of rheumatoid arthritis

  • Presence of known active malignancy

  • Presence of shoulder pain on the affected side within 3 months prior to stroke

  • Patients who demonstrate hemispatial visual neglect based on screening motor-free visual perception test (MFVPT)

  • Patients already receiving any type of manual therapy by a certified therapist through their standard-of-care treatment

  • Patients who do not wish to participate

  • Patients who are not fit as judged by the study team

  • Patients who lack the capacity to consent for enrollment in the study based on the University of California San Diego Brief Assessment of Capacity to Consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 UW Health University Ave Rehabilitation Clinic Middleton Wisconsin United States 53562

Sponsors and Collaborators

  • University of Wisconsin, Madison

Investigators

  • Principal Investigator: Ashley Mohan, DO, University of Wisconsin, Madison

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT06098508
Other Study ID Numbers:
  • 2021-1051
  • SMPH/ORTHO&REHAB/REHAB MED
  • Protocol version 8/9/23
First Posted:
Oct 24, 2023
Last Update Posted:
Oct 24, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Wisconsin, Madison
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 24, 2023